Patents by Inventor Hermann Kurt Russ

Hermann Kurt Russ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of neurodegenerative eye disease using pridopidine
    Patent number: 11738012
    Abstract: The subject invention provides a method of treating a subject afflicted with a neurodegenerative eye disease comprising administering to the subject an amount of pridopidine effective to treat the subject.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: August 29, 2023
    Assignee: PRILENIA NEUROTHERAPEUTICS LTD.
    Inventors: Hermann Kurt Russ, Michal Geva, Ralph Laufer, Aric Orbach
  • CRYSTALLINE FORMS OF SOLVATES OF TRYPTOPHAN DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF
    Publication number: 20230242483
    Abstract: The invention provides crystalline forms of solvates of tryptophan derivatives of compound (1), compositions comprising them, processes for their preparations and methods of use thereof.
    Type: Application
    Filed: May 23, 2021
    Publication date: August 3, 2023
    Applicant: Galimedix Therapeutics Inc.
    Inventors: Jozsef Jozsef REPASI REPASI, Andras SZABO, Hermann Kurt RUSS, Markus HENRICH
  • TREATMENT OF NEURODEGENERATIVE EYE DISEASE USING PRIDOPIDINE
    Publication number: 20220062255
    Abstract: This application provides a method of treating a subject afflicted with a neurodegenerative eye disease comprising administering to the subject an amount of pridopidine effective to treat the subject, pharmaceutical composition and uses and applications thereof.
    Type: Application
    Filed: October 28, 2021
    Publication date: March 3, 2022
    Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
    Inventors: Michal Geva, Hermann Kurt Russ, Ralph Laufer, Aric Orbach
  • TREATMENT OF NEURODEGENERATIVE EYE DISEASE USING PRODOPIDINE
    Publication number: 20190046516
    Abstract: The subject invention provides a method of treating a subject afflicted with a neurodegenerative eye disease comprising administering to the subject an amount of pridopidine effective to treat the subject.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 14, 2019
    Applicant: Teva Pharmaceuticals International GmbH
    Inventors: Hermann Kurt Russ, Michal Geva, Ralph Laufer, Aric Orbach